rs772145843
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4BS1_SupportingBS2
The NM_002047.4(GARS1):c.1138G>A(p.Ala380Thr) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000558 in 1,614,198 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_002047.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GARS1 | ENST00000389266.8 | c.1138G>A | p.Ala380Thr | missense_variant | Exon 9 of 17 | 1 | NM_002047.4 | ENSP00000373918.3 | ||
GARS1 | ENST00000675651.1 | c.1138G>A | p.Ala380Thr | missense_variant | Exon 9 of 17 | ENSP00000502513.1 | ||||
GARS1 | ENST00000675810.1 | c.1036G>A | p.Ala346Thr | missense_variant | Exon 8 of 16 | ENSP00000502743.1 | ||||
GARS1 | ENST00000675693.1 | c.970G>A | p.Ala324Thr | missense_variant | Exon 10 of 18 | ENSP00000502174.1 | ||||
GARS1 | ENST00000675051.1 | c.937G>A | p.Ala313Thr | missense_variant | Exon 9 of 17 | ENSP00000502296.1 | ||||
GARS1 | ENST00000674815.1 | c.769G>A | p.Ala257Thr | missense_variant | Exon 9 of 17 | ENSP00000502799.1 | ||||
GARS1 | ENST00000674851.1 | c.769G>A | p.Ala257Thr | missense_variant | Exon 10 of 18 | ENSP00000502451.1 | ||||
GARS1 | ENST00000444666.6 | n.1138G>A | non_coding_transcript_exon_variant | Exon 9 of 18 | 3 | ENSP00000415447.2 | ||||
GARS1 | ENST00000674616.1 | n.*852G>A | non_coding_transcript_exon_variant | Exon 10 of 18 | ENSP00000502408.1 | |||||
GARS1 | ENST00000674643.1 | n.*238G>A | non_coding_transcript_exon_variant | Exon 10 of 17 | ENSP00000501636.1 | |||||
GARS1 | ENST00000674737.1 | n.*476G>A | non_coding_transcript_exon_variant | Exon 10 of 18 | ENSP00000502464.1 | |||||
GARS1 | ENST00000674807.1 | n.1138G>A | non_coding_transcript_exon_variant | Exon 9 of 16 | ENSP00000502814.1 | |||||
GARS1 | ENST00000675529.1 | n.*1008G>A | non_coding_transcript_exon_variant | Exon 10 of 18 | ENSP00000501655.1 | |||||
GARS1 | ENST00000675859.1 | n.1138G>A | non_coding_transcript_exon_variant | Exon 9 of 15 | ENSP00000502033.1 | |||||
GARS1 | ENST00000676088.1 | n.*1080G>A | non_coding_transcript_exon_variant | Exon 11 of 19 | ENSP00000501884.1 | |||||
GARS1 | ENST00000676140.1 | n.*83G>A | non_coding_transcript_exon_variant | Exon 9 of 17 | ENSP00000502571.1 | |||||
GARS1 | ENST00000676164.1 | n.*589G>A | non_coding_transcript_exon_variant | Exon 9 of 17 | ENSP00000501986.1 | |||||
GARS1 | ENST00000676210.1 | n.*427G>A | non_coding_transcript_exon_variant | Exon 10 of 18 | ENSP00000502373.1 | |||||
GARS1 | ENST00000676259.1 | n.*570G>A | non_coding_transcript_exon_variant | Exon 9 of 17 | ENSP00000501980.1 | |||||
GARS1 | ENST00000676403.1 | n.1138G>A | non_coding_transcript_exon_variant | Exon 9 of 16 | ENSP00000502681.1 | |||||
GARS1 | ENST00000674616.1 | n.*852G>A | 3_prime_UTR_variant | Exon 10 of 18 | ENSP00000502408.1 | |||||
GARS1 | ENST00000674643.1 | n.*238G>A | 3_prime_UTR_variant | Exon 10 of 17 | ENSP00000501636.1 | |||||
GARS1 | ENST00000674737.1 | n.*476G>A | 3_prime_UTR_variant | Exon 10 of 18 | ENSP00000502464.1 | |||||
GARS1 | ENST00000675529.1 | n.*1008G>A | 3_prime_UTR_variant | Exon 10 of 18 | ENSP00000501655.1 | |||||
GARS1 | ENST00000676088.1 | n.*1080G>A | 3_prime_UTR_variant | Exon 11 of 19 | ENSP00000501884.1 | |||||
GARS1 | ENST00000676140.1 | n.*83G>A | 3_prime_UTR_variant | Exon 9 of 17 | ENSP00000502571.1 | |||||
GARS1 | ENST00000676164.1 | n.*589G>A | 3_prime_UTR_variant | Exon 9 of 17 | ENSP00000501986.1 | |||||
GARS1 | ENST00000676210.1 | n.*427G>A | 3_prime_UTR_variant | Exon 10 of 18 | ENSP00000502373.1 | |||||
GARS1 | ENST00000676259.1 | n.*570G>A | 3_prime_UTR_variant | Exon 9 of 17 | ENSP00000501980.1 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152198Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000240 AC: 6AN: 249564Hom.: 0 AF XY: 0.0000222 AC XY: 3AN XY: 135400
GnomAD4 exome AF: 0.00000547 AC: 8AN: 1461882Hom.: 0 Cov.: 31 AF XY: 0.00000550 AC XY: 4AN XY: 727242
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152316Hom.: 0 Cov.: 32 AF XY: 0.0000134 AC XY: 1AN XY: 74490
ClinVar
Submissions by phenotype
Charcot-Marie-Tooth disease type 2 Uncertain:1
This variant is present in population databases (rs772145843, ExAC 0.02%). This sequence change replaces alanine with threonine at codon 380 of the GARS protein (p.Ala380Thr). The alanine residue is moderately conserved and there is a small physicochemical difference between alanine and threonine. This variant has not been reported in the literature in individuals with GARS-related disease. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function do not agree on the potential impact of this missense change (SIFT: "Tolerated"; PolyPhen-2: "Possibly Damaging"; Align-GVGD: "Class C0"). -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at